Saratov JOURNAL of Medical and Scientific Research

Ocular manifestations of coronavirus infection (COVID-19) (clinical cases)

Year: 2021, volume 17 Issue: №3 Pages: 639-642
Heading: Тhematic supplement Article type: Case report
Authors: Kamenskikh T.G., Veselova Е.М., Borisov A.M., Kamenskikh I.D., Sysolyatina I.V.
Organization: Saratov State Medical University, University Clinical Hospital №2 (Clinic of Eye Diseases)
Summary:

Purpose: to present a series of clinical cases demonstrating the spectrum of ophthalmic pathology in patients who have undergone coronavirus infection (COVID-19). COVID-19 can potentially provoke or aggravate the course of autoimmune ophthalmopathology, infectious diseases, vascular occlusions. The considered clinical examples show the most common types of ophthalmopathology that develop on COVID-19 background. The information of the study confirms the importance of a multidisciplinary approach for the management of COVID-19 patients, regardless of the disease severity. The variety of ophthalmic diseases in COVID-19 patients indicates that the changes caused by the virus or accompanying this infection are due not only to its direct action, but also to the activation of latent diseases associated with hereditary or other predisposition. Taking into account the data of modern literature and our experience, we believe that the recognition of COVID-19 as the etiological factor of a number of eye diseases without convincing evidence can lead to misdiagnosis and inappropriate treatment. COVID-19 should be considered as the main etiological factor after excluding all other possible causes of eye diseases.

Bibliography:
1. Wu P, Duan F, Luo C, et al. Characteristics of Ocular Findings of Patients with Coronavirus Disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol 2020 May 01; 138 (5): 575-8.
2. Cheema M, Aghazadeh H, Nazarali S, et al. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Can J Ophthalmol 2020Aug;55(4):e125-9.
3. Colavita F, Lapa D, Carletti F, et al. SARS-CoV-2 Isolation from Ocular Secretions of a Patient with COVID-19 in Italy with Prolonged Viral RNA Detection. Ann Intern Med 2020 Aug 04; 173(3): 242-3.
4. Dockery DM, Rowe SG, Murphy MA, Krzystolik MG. The Ocular Manifestations and Transmission of COVID-19: Recommendations for Prevention. J Emerg Med 2020 Jul; 59 (1): 137-40.
5. Invernizzi A, Torre A, Parrulli S, et al. Retinal findings in patients with COVID-19: Results from the SERPICO-19 study. EClinical Medicine 2020 Oct; 27: 100550.
6. Lecler A, Cotton F, Lersy F, et al. SFNR's COVID Study Group. Ocular MRI Findings in Patients with Severe COVID-19: A Retrospective Multicenter Observational Study. Radiology 2021 May; 299 (2): E226-9.
7. Chin MS, Hooper LC, Hooks JJ, Detrick B. Identification of a-fodrin as an autoantigen in experimental coronavirus retinopathy (ECOR). J Neuroimmunol 2014 Jul 15; 272 (1-2): 42-50.
8. Palao M, Fernandez-Diaz E, Gracia-Gil J, et al. Multiple sclerosis following SARS-CoV-2 infection. Mult Scler Relat Disord 2020 Oct; 45: 102377.
9. Sawalha K, Adeodokun S, Kamoga GR. COVID-19-lnduced Acute Bilateral Optic Neuritis. J Investig Med High Impact Case Rep 2020 Jan-Dec; 8: 2324709620976018.
10. Zhou S, Jones-Lopez EC, Soneji DJ, et al. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis and Myelitis in COVID-19. J Neuroophthalmol 2020 Sep; 40 (3): 398-402.
11. Belghmaidi S, Nassih H, Boutgayout S, et al. Third Cranial Nerve Palsy Presenting with Unilateral Diplopia and Strabismus in a 24-Year-Old Woman with COVID-19. Am J Case Rep 2020 Oct 15;21:e925897.
12. Oliveira RMC, Santos DH, Olivetti ВС, Takahashi JT Bilateral trochlear nerve palsy due to cerebral vasculitis related to COVID-19 infection. Arq Neuropsiquiatr 2020 Jun; 78 (6): 385-6.
13. Turbin RE, Wawrzusin PJ, Sakla NM, et al. Orbital cellulitis, sinusitis and intracranial abnormalities in two adolescents with COVID-19. Orbit 2020 Aug; 39 (4): 305-10.
14. Kurysheva Nl. COVID-19 and damage to the organ of vision. Moscow: LARGO, 2021; 69 p.

AttachmentSize
2021_03-2_639-642.pdf687.39 KB

No votes yet